| Financial Year |
March 31 2023 |
| Monetary Funds |
367,844,370.73 |
| Held-for-trading Financial Assets |
323,391,537.13 |
| Notes Receivable |
1,843,024.29 |
| Accounts Receivable |
109,139,975.78 |
| Advances to Suppliers |
8,484,257.20 |
| Other Receivables |
6,074,182.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
231,711,278.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,332,593.96 |
| Total Current Assets |
1,070,779,950.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,000,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
222,295,725.56 |
| Under-construction Projects |
55,782,281.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
56,114,698.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
986,454.44 |
| Deferred Income Tax Assets |
5,312,594.58 |
| Other Non-Current Assets |
80,755,743.47 |
| Sub-Total of Non-Current Assets |
463,296,498.26 |
| Total Assets |
1,534,076,448.87 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
108,883,415.86 |
| Accounts Payable |
110,440,804.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,588,896.09 |
| Taxes Payable |
13,808,917.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,230,414.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,301,843.82 |
| Sub-Total of Current Liabilities |
267,109,601.55 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,849,481.51 |
| Deferred Income Tax Liabilities |
249,866.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,033,303.54 |
| Total Liabilities |
272,142,905.09 |
| Paid-In Capital(Or Share Stock) |
102,608,133.00 |
| Capital Surplus |
641,534,359.58 |
| Surplus Reserve |
61,172,774.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
456,618,276.53 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,261,933,543.78 |
| Owner's Equity（Stockholder's Equity） |
1,261,933,543.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,534,076,448.87 |
